Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsFOR RX COMPOUNDINGGeneric

ZIBA-RX

BACITRACIN ZINC

Standard Dose
500,000 UNITS/BOT
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ZIBA-RX is listed in Drugs@FDA under application 061737 (ANDA).

Marketing status: Discontinued Active ingredient BACITRACIN ZINC Form and strength POWDER;FOR RX COMPOUNDING - 500,000 UNITS/BOT Sponsor X GEN PHARMS Submission history Latest submission status date: 1994-07-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZIBA-RX is listed in Drugs@FDA under application 061737 (ANDA). Marketing status: Discontinued Active ingredient BACITRACIN ZINC Form and strength POWDER;FOR RX COMPOUNDING - 500,000 UNITS/BOT Sponsor X GEN PHARMS Submission history Latest submission status date: 1994-07-29 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.